One week, a daily shot of olive oil is the key to a thriving microbiome. The next, it’s useless. Fermented foods are essential, until an article informs you they’re overhyped. If you’ve ever felt like gut health advice can’t keep its story straight, you’re not imagining it. And a recent editorial in The Lancet Microbe explains why: the science itself, in many ways, is still figuring things out.
That’s not a reason to tune out gut health. It’s a reason to get better at reading it. Below, we review the reasons why microbiome studies often contradict each other.
How New is Microbiome Science, Really?
It’s newer than the wellness aisle would suggest. People have been looking at gut microbes since 1681, when Antonie van Leeuwenhoek peered at his own stool (gross, but thanks for your contribution to science, Mr. Leeuwenhoek) through an early microscope and described “more than 1000 living animalcules” swimming around. The first gut microbiome study in history was a guy examining his own you-know-what. The study sample of choice hasn’t changed much since.
For the next 300 years, though, the field barely evolved, because most gut bacteria die if you try to grow them in a lab dish. It wasn’t until DNA sequencing arrived that scientists could finally identify what was going on down there without having to grow gut bacteria in a lab dish. The tools that make modern microbiome research possible are only a few decades old. We now estimate around 100 trillion microbes live in each person’s gut, and we’re still early in working out what most of them actually do.
So Why Do Studies Disagree?
There are a few reasons, and they’re worth knowing, because they’ll help you spot a flimsy headline.
First, most gut studies are observational. They notice that people with a certain condition tend to have a certain bacterial makeup. But a pattern isn’t proof of cause. If a study finds that people with a gut disorder have less of some bacterium, that alone can’t tell you whether the low bacterium caused the disorder, the disorder depleted the bacterium, or some third thing drove both. The Lancet editorial’s authors argue the field needs to move from cataloging which species are present toward understanding why they’re there and what they’re doing.
Second, there’s no standard evaluation playbook. Different labs collect samples differently, extract DNA differently, and run their sequencing differently. Those differences alone can produce inconsistent, even contradictory results from what should be the same question. When two studies “disagree,” sometimes the disagreement is real. Sometimes it’s just two labs using two different methods.
Third (and this is the part that calls back to van Leeuwenhoek), most microbiome research still runs on stool samples, because they’re easy to collect. But your stool mostly reflects what’s going on at the end of your colon, not the full length of your gut. Some argue that it’s a useful snapshot of one region, not a complete map.
We need to standardize testing methods and broaden what they test before the industry can reach a consensus.
Who Has Microbiome Science Actually Studied?
Also, we haven’t studied a very representative slice of humanity. The editorial notes that most microbiome research has been conducted in wealthy countries, on White European and North American populations. We know about the diseases that are common in those settings. One major microbial database was composed of roughly half European and North American samples.
That matters, because your microbiome is shaped by diet, geography, and lifestyle. A picture of “healthy gut” built mostly from one part of the world may not describe everyone’s gut equally well. Species common in under-studied populations can be missed or misclassified entirely.
So Should You Ignore Gut Health Advice?
No. You should look at it through a specific lens.
Here’s a practical filter. Be skeptical of anything promising that a single intervention will transform your microbiome, especially when it leans on one small study. Give more weight to the boring, well-replicated stuff: dietary fiber, plant diversity, fermented foods, not smoking, limiting unnecessary antibiotics, and taking high-quality supplements. Those show up as beneficial across many studies using many different methods, which is exactly the kind of consistency the shaky findings lack. Consistency over novelty is the whole game.
IgY Max works through a specific, well-characterized mechanism: antibodies that target and clear 26 known dysbiosis-causing pathogens, rather than a vague promise to “boost your good bacteria.” The mechanism is solid. The clinical picture is still building.
If the Lancet editorial has one message, it’s that humility is the correct posture toward the gut right now. The microbiome is staggeringly complex. As of now, scientists are in the early stages of understanding it, and anyone who tells you it’s all figured out is selling you something. Sticking to well-established interventions is the right move.
The Bottom Line
Gut health advice contradicts itself because the science is young, the methods aren’t standardized, and a lot of what we know is correlation rather than cause. That’s not a scandal; it’s what an evolving field looks like. Your best move as a reader is to trust consistency over novelty, stay wary of miracle claims, and give the well-replicated basics more weight than the headline of the week.
Learn more about supporting your gut at igynutrition.com.
References
- The human gut microbiome: still more questions than answers. The Lancet Microbe, Vol 7, August 2026. https://doi.org/10.1016/j.lanmic.2026.101513
- NIH Human Microbiome Project. https://commonfund.nih.gov/hmp
